Nerve growth factor and norepinephrine concentrations in weight-bearing and non-weight-bearing bones of euthyroid and hyperthyroid rats

Journal of Musculoskeletal Neuronal Interactions

Volumn 2, Issue 4, 2002, Pages 327-334

  Yao, M ^a   Dooley, P C ^a   Schuijers, J A ^a   Grills, Brian L ^a  

^a LA TROBE UNIVERSITY   (Australia)

Author keywords

Bone; Hyperthyroidism; Nerve growth factor; Norepinephrine; Weight bearing

Indexed keywords

LIOTHYRONINE; NERVE GROWTH FACTOR; NORADRENALIN; THYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE ATROPHY; CALVARIA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTROCHEMICAL DETECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EUTHYROIDISM; FEMUR; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE ACTION; HORMONE BLOOD LEVEL; HYPERTHYROIDISM; MALE; MORPHOMETRICS; NONHUMAN; OSSIFICATION; RAT; RIB; TIBIA; TRABECULAR BONE; WEIGHT BEARING;

EID: 0036620987     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Mosekilde L, Eriksen EF, Charles P. Effects of thyroid hormone on bone and mineral metabolism. Endocrinol Metab Clin North Am 1990; 19:35-63.
2. Bijlsma JWJ, Duursma SA, Roelofs JMM, der Kindren PJ. Thyroid function and bone turnover. Acta Endocrinol (Copenh) 1983; 104:42-49.
3. Allain TJ, McGregor AM. Review: Thyroid hormones and bone. J Endocrinol 1993; 139:9-18.
4. Klaushofer K, Varga F, Glantschnig H, Fratzl-zelman N, Czerwenka E, Leis HJ, Koller K, Peterlik M. The regulatory role of thyroid hormones in bone cell growth and differentiation. Intern Con Prog Bone Min Res 1995; (suppl): 1996S-2003S.
5. Siddiqi A, Monson JP, Wood DF, Besser GM, Burrin, JM. Serum cytokines in thyrotoxicosis. J Clin Endocrinol Metab 1999; 84:435-439.
6. Garcia-Castellano JM, Diaz-Herrera P, Morcuende JA. Is bone a target-tissue for the nervous system? New advances on the understanding of their interactions. Iowa Orthop J 2000 20:49-58.
7. Barakat-Walter I. Role of thyroid hormones and their receptors in peripheral nerve regeneration. J Neurobiol 1999; 40:541-559.
8. Frenkel SR, Guerra LA, Mitchell OG, Singh IJ. Nerve growth factor in skeletal tissues of the embryonic chick. Cell Tissue Res 1990; 260:507-511.
9. Grills BL, Schuijers JA. Immunohistochemical localization of nerve growth factor in fractured and unfractured rat bone. Acta Orthop Scand 1998; 69:415-419.
10. Asaumi D, Nakanishi T, Asahara H, Inoue H, Takigawa A. Expression of neuropeptides and their receptors (TRK) during fracture healing. Bone 2000; 26:625-633.
11. Jehan F, Naveilhan P, Neveu I, Harvie D, Dicou KE, Brachet P, Wion D. Regulation of NGF, BDNF and LNGFR gene expression in ROS 17/2.8 cells. Mol Cell Endocrinol 1996; 116:149-156.
12. Grills BL, Schuijers JA, Ward AR. Topical application of nerve growth factor improves fracture healing in rats. J Orthop Res 1997; 15:235-242.
13. Eppley BL, Snyderes RV, Winkelmann TM, Roufa DG. Efficacy of nerve growth factor in regeneration of mandibular nerve. J Oral Maxillofac Surg 1991; 49:61-68.
14. Walker P, Weichsel ME Jr, Guo SM, Fisher DA, Fisher DA. Radioimmunoassay for mouse nerve growth factor (NGF). Effects of thyroxine administration on tissue NGF levels. Brain Res 1980; 186:331-341.
15. Black MA, Pope L, Lefebvre F-A, Lefebvre YA, Walker P. Thyroid hormones precociously increase nerve growth factor gene expression in the submandibular gland of neonatal mice. Endocrinology 1992; 130:2083-2090.
16. Sisask G, Bjurholm A, Ahmed M, Kreicbergs A. The development of autonomic innervation in bone and joints of the rat. J Auton Nerv Syst 1996; 59:27-33.
17. Moore RE, Smith CK, Bailey CS, Voelkel EF, Tashjian AH Jr. Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture. Bone Miner 1993; 23:301-315.
18. Christensen NJ. Plasma noradrenaline and adrenaline in patients with thyrotoxicosis and myxoedema. Clin Sci Mol Med 1973; 45:163-173.
19. Mano T, Sakamoto H, Fujita K, Makino M, Kakizawa H, Nagata M, Kotake M, Hamada M, Uchimura K, Hayakawa N, Hayashi R, Nakai A, Itoh M, Kuzuya H, Nagasaka A. Effects of thyroid hormone on catecholamine and its metabolite concentrations in rat cardiac muscle and cerebral cortex. Thyroid 1998; 8: 353-358.
20. Frost HM. From Wolff's Law to the Utah paradigm: Insights about bone physiology and its clinical applications. Anat Rec 2001; 262:398-419.
21. Finkelman RD, Eason AL, Rakijian DR, Tutundzhyan Y, Hardesty RA. Elevated IGF-II and TGF-beta concentrations in human calvarial bone: potential mechanism for increased graft survival and resistance to osteoporosis. Plast Reconstr Surg 1994; 93:732-738.
22. Finkelstein DI, Dooley PC, Luff AR. Recovery of muscle after different periods of denervation and treatments. Muscle Nerve 1993; 16:769-777.
23. Fitzsimons DP, Herrick RE, Baldwin RM. Isomyosin distribution in rodent muscles: effects of altered thyroid state. J Appl Physiol 1990; 69:321-329.
24. Grills BL, Gallagher JA, Allan EA, Yumita S, Martin TJ. Identification of plasminogen activator in osteoclasts. J Bone Miner Res 1990; 5:499-505.
25. Bancroft JD, Stevens A. Theory and practice of histological techniques, 4th edition. Churchill Livingstone, New York; 1996:332-334.
26. Bennett AD, Taglialatela G, Preze-Polo R, Hulsebosh CE. NGF levels decrease in the spinal cord and dorsal root ganglion after spinal hemisection. Neuroreport 1999; 10:889-893.
27. Schuijers JA, Walker DW, Browne CA, Thornburn GD. Effect of hypoxemia on plasma catecholamines in intact and immunosympathectomized fetal lambs. Am J Physiol 1986; 251:R893-R900.
28. Davies DT. Assessment of rodent thyroid endocrinology: Advantages and pitfalls. Comp Hematol Intern 1993; 3:142-152.
29. Carter WJ, Lynch ME. Effect of clenbuterol on recovery of muscle mass and carcass protein content following experimental hyperthyroidism in old rats. Comp Biochem Physiol Comp Physiol 1994; 108:387-394.
30. Grofte T, Wolthers T, Jensen DS, Moller N, Jorgensen JOL, Orskov H, Vilstrup H. Hepatic amino nitrogen conversion and organ N-contents in hypothyroidism, with thyroxine replacement, and in hyperthyroid rats. J Hepatol 1997; 26:409-416.
31. Allain TJ, Thomas MR, McGregor AM, Salisbury JR. A histomorphometric study of bone changes in thyroid dysfunction in rats. Bone 1995; 16:505-509.
32. Melsen F, Mosekilde L. Morphometric and dynamic studies of bone changes in hyperthyroidism. Acta Pathol Microbiol Scand 1977; 85:141-150.
33. Alberius P, Skagerberg G. Adrenergic innervation of the calvarium of the neonatal rat. Its relationship to the sagittal suture and developing parietal bones. Anat Embryol (Berl) 1990; 182:493-498.
34. Bjurholm A, Kreicbergs A, Terenuis L, Goldstein M, Schultzberg M. Neuropeptide Y-, tyrosine hydroxylase- and vasoactive intestinal polypeptide-immunoreactive nerves in bone and surrounding tissues. J Auton Nerv Syst 1988; 25:119-125.
35. Simmons DJ, Gorynpas MD, Rosenberg GD. Maturation of bone and dentin matrices in rats flown on the Soviet biosatellite Cosmos 1887. FASEB J 1990; 4:29-33.
36. Miyamoto A, Shigematsu T, Fukunaga T, Kawakami K, Mukai C, Sekiguchi C. Medical baseline data collection on bone and muscle change with space flight. Bone 1998; 22(5 Suppl): 79S-82S.
37. Giordano T, Pan JB, Casuto D, Watanabe S, Arneric SP. Thyroid hormone regulation of NGF, NT-3 and BDNF RNA in the adult rat brain. Brain Res Mol Brain Res 1992; 16:239-245.
38. Suwanwalaikorn S, Ongphiphadhanakul B, Braverman LE, Baran DT. Differential responses of femoral and vertebral bones to long-term excessive L-thyroxine administration in adult rats. Eur J Endocrinol 1996; 134:655-659.
39. Levi-Montalcini R, Angeletti PU. The nerve growth factor. Physiol Rev 1968; 48:534-569.
40. Nakanishi T, Takahashi K, Aoki C, Nishikawa K, Hattori T, Taniguch S. Expression of nerve growth factor family neurotrophins in a mouse osteoblastic cell line. Biochem Biophys Res Comm 1994; 198:891-897.
41. Uebergang T, Thomas R, Gillespie M, Grills B. Nerve growth factor (NGF) and NGF receptor mRNA expression in UMR 201 and UMR 106.01 cells. Proc ANZBMS 1999; 9:63.
42. Bayliss RIS, Edwards OM. Urinary excretion of free catecholamines in Graves' disease. Endocrinology 1971; 49:167-173.
43. Beaven MA, Costa E, Brodie BB. The turnover of norepinephrine in thyrotoxic and nonthyrotoxic mice. Life Sci 1963; 4:241-246.
44. Gripois D, Fernandez C. Effects of thyroid hormones on the evolution of monoamine oxidase activity in the brain and heart of the developing rat. Enzyme 1977; 22:378-384.
45. Lyles GA, Callingham BA. The effects of thyroid hormones on monoamine oxidase in the rat heart. J Pharm Pharmacol 1974; 26:921-930.
46. Togari A, Arai M, Mizutani S, Mizutani S, Koshihara Y, Nagatsu T. Expression of mRNAs for neuropeptide receptors and beta-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells. Neurosci Lett 1997; 233:125-128.
47. Skrabanek P. Catecholamines cause the hypercalciuria and hypercalcaemia in phaeochromocytoma and in hyperthyroidism. Med Hypotheses 1977; 3:59-62.
48. Hellstrom L, Wahrenberg H, Reynisdottir S, Arner P. Catecholamine-induced adipocyte lipolysis in human hyperthyroidism. J Clin Endocrinol Metab 1997; 82:159-66.
49. Britto JM, Fenton AJ, Holloway WR, Nicholson GC. Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption. Endocrinology 1994; 134:69-176.
50. Allain TJ, Chambers TJ, Flanagan AM, McGregor AM. Tri-iodothyronine stimulates rat osteoclastic bone resorption by an indirect effect. J Endocrinol 1992; 133:327-331.
51. Glass CK, Holloway JM. Regulation of gene expression by the thyroid hormone receptor. Biochim Biophys Acta 1990; 1032:157-176.